Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23160)

• Formulation Name: Etelcalcetide 5 mg/ml Injection
• Company: Amgen

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Etelcalcetide	(DMHP9BL)	Secondary hyperparathyroidism	5A51.1	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Hydrochloric acid	(E00015)	313	Acidulant
Sodium chloride	(E00077)	5234	Diluent; Tonicity agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Succinic acid	(E00044)	1110	Buffering agent